Based on the Oruka Therapeutics, Inc. stock forecast from 5 analysts, the average analyst target price for Oruka Therapeutics, Inc. is USD 42.63 over the next 12 months. Oruka Therapeutics, Inc.’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Oruka Therapeutics, Inc. is Very Bullish, which is based on 1 positive signals and 0 negative signals. At the last closing, Oruka Therapeutics, Inc.’s stock price was USD 21.13. Oruka Therapeutics, Inc.’s stock price has changed by -0.98% over the past week, +14.15% over the past month and 0% over the last year.
No recent analyst target price found for Oruka Therapeutics, Inc.
No recent average analyst rating found for Oruka Therapeutics, Inc.
Company Overview Oruka Therapeutics, Inc.
Oruka Therapeutics, Inc. operates as a biotechnology company. The Company develops novel biologics designed for the treatment of chronic skin diseases, including plaque psoriasis and other inflammatory diseases. Oruka Therapeutics serves patients in the United States. Read Less
Oruka Therapeutics, Inc. operates as a biotechnology company. The Company develops novel biologics designed for the treatment of chronic skin diseases, including plaque psoriasis and other inflammatory diseases. Oruka Therapeutics serves patients in the United States.
N/A
N/A
N/A
N/A
USD
USA
Adjusted Closing Price for Oruka Therapeutics, Inc. (ORKA)
Loading...
Unadjusted Closing Price for Oruka Therapeutics, Inc. (ORKA)
Loading...
Share Trading Volume for Oruka Therapeutics, Inc. Shares
Loading...
Compare Performance of Oruka Therapeutics, Inc. Shares
Symbol
Capital Gain
Dividend Return
Total Return
Loading...
Loading...
Technical Indicators for ORKA
Assets
Top Holdings
N/A
Top Sectors
Top Regions
Stocks Similar To Oruka Therapeutics, Inc. (Sector: Others )
Frequently Asked Questions About Oruka Therapeutics, Inc. (ORKA) Stock
Based on ratings from 5 analysts Oruka Therapeutics, Inc.'s stock is Strong Buy. Stock Target Advisor's fundamental analysis is Very Bullish. The stock has 8 buy, sell and hold ratings.
ORKA stock's dividend yield is 77.77%.
Our analysis grades ORKA stock's dividend yield at A+. This means that ORKA stock's dividend yield is above 97% of the stocks in the Others sector in the NSD exchange.
Based on this ORKA may be a good dividend stock for its sector.
Based on targets from 5 analysts, the average taret price for ORKA is USD 42.63 over the next 12 months. The maximum analyst target price is USD 45 while the minimum anlayst target price is USD 40.
Unfortunately we do not have enough data on ORKA's stock to indicate if its overvalued.
The last closing price of ORKA's stock was USD 21.13.
The most recent market capitalization for ORKA is USD 0.89B.
Based on targets from 5 analysts, the average taret price for ORKA is projected at USD 42.63 over the next 12 months.
This means that ORKA's stock price may go up by +101.73% over the next 12 months.
We can't find any ETFs which contains Oruka Therapeutics, Inc.'s stock.
Sorry, we do not have any data on the number of employees for Oruka Therapeutics, Inc..
Sorry we do not have any infomation available on Oruka Therapeutics, Inc.'s address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
What not to like
There is nothing we particularly dislike
Frequently Asked Questions About Oruka Therapeutics, Inc. (ORKA) Stock
Based on ratings from 5 analysts Oruka Therapeutics, Inc.'s stock is Strong Buy. Stock Target Advisor's fundamental analysis is Very Bullish. The stock has 8 buy, sell and hold ratings.
ORKA stock's dividend yield is 77.77%.
Our analysis grades ORKA stock's dividend yield at A+. This means that ORKA stock's dividend yield is above 97% of the stocks in the Others sector in the NSD exchange.
Based on this ORKA may be a good dividend stock for its sector.
Based on targets from 5 analysts, the average taret price for ORKA is USD 42.63 over the next 12 months. The maximum analyst target price is USD 45 while the minimum anlayst target price is USD 40.
Unfortunately we do not have enough data on ORKA's stock to indicate if its overvalued.
The last closing price of ORKA's stock was USD 21.13.
The most recent market capitalization for ORKA is USD 0.89B.
Based on targets from 5 analysts, the average taret price for ORKA is projected at USD 42.63 over the next 12 months.
This means that ORKA's stock price may go up by +101.73% over the next 12 months.
We can't find any ETFs which contains Oruka Therapeutics, Inc.'s stock.
Sorry, we do not have any data on the number of employees for Oruka Therapeutics, Inc..
Sorry we do not have any infomation available on Oruka Therapeutics, Inc.'s address.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for ORKA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
